ERJ Open Res 2020 Oct
Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.
Related Questions
What is your preferred management for diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)?
1 Answers
Mednet Member
Medical Oncology · Mayo Clinic
The management of patients with DIPNECH is predominantly symptomatic but DIPNECH is a chronic disease, often with significant respiratory symptoms such as dyspnea and cough but the severity of the symptoms varies over time.I recommend involving pulmonary medicine early on as the management can resem...
Is there a role of everolimus or capecitabine and temozolomide in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia in patients already on octreotide?
1 Answers
Mednet Member
Medical Oncology · Mayo Clinic
The key question is why there is a reason to change the treatment... Is it for worsening symptoms or progressive disease with overt lung NET development or progression of known lung NET?In a retrospective study of 55 patients with DIPNECH, only 18% had a progression to a lung NET (typical carcinoid)...